Antifungal therapy for invasive fungal diseases in allogeneic stem cell transplant recipients: an update (Q37421528)

20 August 2017

1 reference

title

Antifungal therapy for invasive fungal diseases in allogeneic stem cell transplant recipients: an update (English)

1 reference

stem cell transplantation

20 August 2017

main subject

1 reference

3

John R Perfect

1 reference

20 August 2017

Dustin T Wilson

1

1 reference

20 August 2017

Richard H Drew

series ordinal

2

1 reference

20 August 2017

publication date

24 March 2009

1 reference

20 August 2017

number of pages

15

1 reference

inferred from page(s)

published in

Mycopathologia

1 reference

20 August 2017

volume

168

1 reference

20 August 2017

issue

6

1 reference

20 August 2017

page(s)

313-327

1 reference

Pretreatment regimens for adverse events related to infusion of amphotericin B.

20 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11046-009-9193-9

Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11046-009-9193-9

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11046-009-9193-9

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

21 January 2018

1 reference

12 December 2020

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

1 reference

12 December 2020

High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial

1 reference

12 December 2020

Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.

1 reference

12 December 2020

Fungal infections after bone marrow transplant

1 reference

12 December 2020

Posaconazole as salvage therapy for zygomycosis

1 reference

12 December 2020

Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America

1 reference

12 December 2020

Echinocandins for candidemia in adults without neutropenia

1 reference

12 December 2020

Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial

1 reference

12 December 2020

Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required

1 reference

12 December 2020

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

1 reference

12 December 2020

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

12 December 2020

Intravenous itraconazole

1 reference

12 December 2020

Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.

1 reference

12 December 2020

A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients

1 reference

12 December 2020

Recent advances and challenges in the treatment of invasive fungal infections

1 reference

12 December 2020

Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.

1 reference

12 December 2020

Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study

1 reference

12 December 2020

Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.

1 reference

12 December 2020

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases

1 reference

12 December 2020

International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia.

1 reference

12 December 2020

Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial).

1 reference

12 December 2020

1 reference

12 December 2020

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

1 reference

12 December 2020

Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections

1 reference

12 December 2020

Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

1 reference

12 December 2020

Anidulafungin versus fluconazole for invasive candidiasis

1 reference

12 December 2020

A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS

1 reference

12 December 2020

The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy

1 reference

12 December 2020

Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.

1 reference

12 December 2020

Amphotericin B: time for a new "gold standard".

1 reference

12 December 2020

Drug interaction assessment following concomitant administration of posaconazole and phenytoin in healthy men

1 reference

12 December 2020

Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes

1 reference

12 December 2020

Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazole

1 reference

12 December 2020

Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility

1 reference

12 December 2020

Current options in antifungal pharmacotherapy.

1 reference

12 December 2020

Economic analysis of micafungin versus liposomal amphotericin B for treatment of candidaemia and invasive candidiasis in Germany.

1 reference

12 December 2020

Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient

1 reference

12 December 2020

Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study

1 reference

12 December 2020

Concomitant cyclosporine and micafungin pharmacokinetics in healthy volunteers

1 reference

12 December 2020

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

1 reference

12 December 2020

Amphotericin B lipid soluble formulations vs amphotericin B in cancer patients with neutropenia

1 reference

12 December 2020

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

1 reference

12 December 2020

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis.

1 reference

12 December 2020

Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study

1 reference

12 December 2020

Caspofungin for the treatment of less common forms of invasive candidiasis

1 reference

12 December 2020

Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis

1 reference

12 December 2020

Effect of oral posaconazole on the pharmacokinetics of cyclosporine and tacrolimus

1 reference

12 December 2020

Evaluation of the pharmacokinetics of posaconazole and rifabutin following co-administration to healthy men.

1 reference

12 December 2020

Aspergillosis case-fatality rate: systematic review of the literature

1 reference

12 December 2020

Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients

1 reference

12 December 2020

Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae

1 reference

12 December 2020

Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model

1 reference

12 December 2020

Study of renal safety in amphotericin B lipid complex-treated patients

1 reference

12 December 2020

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1 reference

12 December 2020

Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group

1 reference

12 December 2020

Potential role of aerosolized amphotericin B formulations in the prevention and adjunctive treatment of invasive fungal infections

1 reference

12 December 2020

Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion test

1 reference

12 December 2020

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

1 reference

12 December 2020

A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).

1 reference

12 December 2020

Advances in antifungal therapy

1 reference

12 December 2020

Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis

1 reference

12 December 2020

Guidelines for treatment of candidiasis

1 reference

12 December 2020

Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment

1 reference

12 December 2020

Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients

1 reference

12 December 2020

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

1 reference

12 December 2020

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

1 reference

12 December 2020

The solubility ceiling: a rationale for continuous infusion amphotericin B therapy?

1 reference

12 December 2020

Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities

1 reference

12 December 2020

Immune reconstitution syndrome associated with opportunistic mycoses

1 reference

12 December 2020

Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis

1 reference

12 December 2020

Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations

1 reference

12 December 2020

Voriconazole therapeutic drug monitoring.

1 reference

12 December 2020

Continuous and 4 h infusion of amphotericin B: a comparative study involving high-risk haematology patients.

1 reference

12 December 2020

Clinical pharmacokinetics of voriconazole.

1 reference

12 December 2020

Liposomal amphotericin B: clinical experience and perspectives

1 reference

12 December 2020

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

12 December 2020

Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis

1 reference

12 December 2020

Antifungal serum concentration monitoring: an update

1 reference

12 December 2020

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

1 reference

12 December 2020

Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.

1 reference

12 December 2020

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)

1 reference

12 December 2020

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis

1 reference

12 December 2020

Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial

1 reference

12 December 2020

Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis

1 reference

12 December 2020

Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections.

1 reference

12 December 2020

Combination antifungal therapy for invasive aspergillosis

1 reference

12 December 2020

Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program

1 reference

12 December 2020

Comparison of caspofungin and amphotericin B for invasive candidiasis

1 reference

12 December 2020

Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole

1 reference

12 December 2020

Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia

1 reference

12 December 2020

Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults

1 reference

12 December 2020

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

1 reference

12 December 2020

A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients

1 reference

12 December 2020

Cyclophosphamide metabolism is affected by azole antifungals

1 reference

12 December 2020

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

1 reference

12 December 2020

Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial

1 reference

12 December 2020

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

1 reference

12 December 2020

Oral bioavailability of posaconazole in fasted healthy subjects: comparison between three regimens and basis for clinical dosage recommendations

1 reference

12 December 2020

Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans.

1 reference

12 December 2020

Safety profile of concomitant use of caspofungin and cyclosporine or tacrolimus in liver transplant patients

1 reference

12 December 2020

Recent advances in antifungal chemotherapy

1 reference

12 December 2020

Update on management of infections in cancer and stem cell transplant patients

1 reference

12 December 2020

Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group

1 reference

12 December 2020

Voriconazole: a new triazole antifungal agent

1 reference

12 December 2020

Continuous infusion of escalated doses of amphotericin B deoxycholate: an open-label observational study

1 reference

12 December 2020

Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases

1 reference

12 December 2020

Invasive candidiasis in the intensive care unit

1 reference

12 December 2020

A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group

1 reference

12 December 2020

Posaconazole mono- or combination therapy for treatment of murine zygomycosis

1 reference

12 December 2020

10.1007/S11046-009-9193-9

Identifiers

DOI

1 reference

20 August 2017

1 reference